OBJECTIVES: The choice of the cardiac preservation solution for myocardial protection at time of heart procurement remains controversial and uncertainties persist regarding its effect on the early and midterm heart transplantation (HTx) outcomes. We retrospectively compared our adult HTx performed with 2 different solutions, in terms of hospital mortality, mid-term survival, inotropic score, primary graft dysfunction and rejection score. METHODS: From January 2009 to December 2020, 154 consecutive HTx of adult patients, followed up in pre- and post-transplantation by 2 different tertiary centres, were performed at the University Hospital of Lausanne, Switzerland. From 2009 to 2015, the cardiac preservation solution used was exclusively St-Thomas, whereafter an institutional decision was made to use HTK-Custodiol only. Patients were classified in 2 groups accordingly. RESULTS: There were 75 patients in the St-Thomas group and 79 patients in the HTK-Custodiol group. The 2 groups were comparable in terms of preoperative and intraoperative characteristics. Postoperatively, compared to the St-Thomas group, the Custodiol group patients showed significantly lower inotropic scores [median (interquartile range): 35.7 (17.5–60.2) vs 71.8 (31.8–127), P < 0.001], rejection scores [0.08 (0.0–0.25) vs 0.14 (0.05–0.5), P = 0.036] and 30-day mortality rate (2.5% vs 14.7%, P = 0.007) even after adjusting for potential confounders. Microscopic analysis of the endomyocardial biopsies also showed less specific histological features of subendothelial ischaemia (3.8% vs 17.3%, P = 0.006). There was no difference in primary graft dysfunction requiring postoperative extracorporeal membrane oxygenation. The use of HTK-Custodiol solution significantly improved midterm survival (Custodiol versus St-Thomas: hazard ratio = 0.20, 95% confidence interval: 0.069–0.60, P = 0.004). CONCLUSIONS: This retrospective study comparing St-Thomas solution and HTK-Custodiol as myocardial protection during heart procurement showed that Custodiol improves outcomes after HTx, including postoperative inotropic score, rejection score, 30-day mortality and midterm survival.
Introduction: Dorsal penile nerve block (DPNB) using anatomical landmarks remains the technique of choice for analgesia during circumcision. Ultrasound guidance has been shown to be safer and more effective. However, a recent study reported no differences between US-DPNB and DPNB in terms of analgesia. Thus, reverse US dorsal penile nerve block (RUS–PNB) has been developed, which is the image mirror of US-DPNB.Aims: Comparison between RUS–PNB and DPNB in terms of efficacy, safety, and speed of execution.Methods: This is a single-center retrospective study. Patients were all males, aged <16 years who underwent circumcision between 1 November 2019 and 31 December 2020. Exclusion criteria were undergoing another surgical procedure during the same operation, not undergoing a block, or refusing to participate. All patients received bupivacaine 0.5% using either DPNB or RUS-PNB. Data including demographic background information, doses of opioids used converted into an equivalent morphine dose per kilogram, different times taken for various medical acts, and complications were collected.Results: A total of 139 patients were included. 45 (Group 1) underwent DPNB and 94 (group 2) underwent RUS–PNB. There were no differences in age, weight, height, or ASA scores between the groups. The per-operative morphine equivalent dose was Group 1; mean 0.5 mg/kg ± 0.2, Group 2; mean 0.2 mg/kg ± 0.2, with p < 0.001. The mean postoperative morphine equivalent dose, duration of anesthesia, and surgery were similar. The volume required was higher for Group 2; median 0.3 ml/kg than for Group 1; median 0.2 ml/kg. There were no complications, although two instances of block failures (4.7%) were observed in group 1 and three (3.3%) in group 2 (p = 0.653). This was due to the need for additional opioids during surgery.Conclusion: The RUS–PNB technique is more efficient than the traditional DPNB method and does not require a longer procedure. It is likely that the incidence of complications is lower when the RUS-DPNB technique is employed, as the injection is performed “under vision” in contrast to the landmark method, which is carried out “blindly” as it results in fewer complications.
13 September 2022 in Journal of Cardiothoracic and Vascular Anesthesia
Introduction: The choice of Cardiac Preservation Solution (CPS) for myocardial protection at the time of heart procurement remains controversial and uncertainties persist regarding its effect on the early and midterm Heart Transplantation (HTx) outcomes. Thus, we retrospectively analyzed our adult HTx performed with two different CPS, during a period of 12 years, in terms of hospital mortality, mid-term survival, inotropic score, primary graft dysfunction and rejection score. Methods: From January 2009 to December 2020, 154 adult HT were performed in our hospital. Patients were divided in two groups according to the CPS used: St. Thomas (n=75, group P 1) and HTK-Custodiol (n=79, group P 2). The choice of CPS was related to an institutional policy; from 2009 to 2015, St. Thomas solution was exclusively used, and after that, HTK-Custodiol alone. Results: There was no significant difference between the two groups in terms of preoperative and intraoperative features. Postoperatively, the Custodiol group showed significantly lower inotropic score (p<0.0001), mean rejection score (p= 0.036) and 30 days mortality (p=0.0068). The use of HTK-Custodiol was the only variable that improved midterm survival (HTK-Custodiol vs St Thomas, HR= 0.20 (95% CI: 0.069 -0.6) p=0.0039). Conclusion: In our single center experience, using HTK-Custodiol as myocardial protection during heart procurement leads to improved outcomes after HTx, including postoperative inotropic score, rejection score, 30-days mortality and midterm survival.